Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Causality in Epidemiology01:21

Causality in Epidemiology

2.0K
Causality or causation is a fundamental concept in epidemiology, vital for understanding the relationships between various factors and health outcomes. Despite its importance, there's no single, universally accepted definition of causality within the discipline. Drawing from a systematic review, causality in epidemiology encompasses several definitions, including production, necessary and sufficient, sufficient-component, counterfactual, and probabilistic models. Each has its strengths and...
2.0K
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation01:24

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

1.4K
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
1.4K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

310
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
310
Friedman Two-way Analysis of Variance by Ranks01:21

Friedman Two-way Analysis of Variance by Ranks

561
Friedman's Two-Way Analysis of Variance by Ranks is a nonparametric test designed to identify differences across multiple test attempts when traditional assumptions of normality and equal variances do not apply. Unlike conventional ANOVA, which requires normally distributed data with equal variances, Friedman's test is ideal for ordinal or non-normally distributed data, making it particularly useful for analyzing dependent samples, such as matched subjects over time or repeated measures...
561
Criteria for Causality: Bradford Hill Criteria - II01:28

Criteria for Causality: Bradford Hill Criteria - II

1.5K
The Bradford Hill criteria serve as guidelines for establishing causative links in epidemiological research. Beyond Strength, Consistency, Specificity, and Temporality, key criteria also include Biological Gradient, Plausibility, Coherence, Experiment, and Analogy. These principles assist scientists in assessing the likelihood of causation in complex biological contexts. Below is a summary of these concepts:
1.5K
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

321
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
321

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Scale-invariant evolution: Comment on "homo informatio" by Michael Walker.

Physics of life reviews·2026
Same author

Testing and tracking in the UK: A dynamic causal modelling study.

Wellcome open research·2026
Same author

Functional neuroanatomy of musical object processing in Alzheimer's disease and frontotemporal dementia.

Brain communications·2026
Same author

The body does not keep the score: trauma, predictive coding, and the restoration of metastability.

Frontiers in systems neuroscience·2026
Same author

The dysconnection hypothesis of schizophrenia: a 30-year update.

World psychiatry : official journal of the World Psychiatric Association (WPA)·2026
Same author

The methodological foundations of lesion network mapping remain sound.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: Mar 29, 2026

Following the Dynamics of Structural Variants in Experimentally Evolved Populations
04:52

Following the Dynamics of Structural Variants in Experimentally Evolved Populations

Published on: February 3, 2023

1.4K

Empirical Bayes for DCM: A Group Inversion Scheme.

Karl Friston1, Peter Zeidman1, Vladimir Litvak1

  • 1The Wellcome Trust Centre for Neuroimaging, University College London London, UK.

Frontiers in Systems Neuroscience
|December 8, 2015
PubMed
Summary
This summary is machine-generated.

This study introduces an empirical Bayesian method to integrate multi-subject brain data for estimating conserved functional brain architectures. This approach enhances the robustness and efficiency of estimating within- and between-subject effects in dynamic causal modeling.

Keywords:
Bayesian model reductiondynamic causal modelingempirical Bayesfixed effectshierarchical modelingrandom effects

More Related Videos

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types
12:39

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types

Published on: December 10, 2012

11.8K

Related Experiment Videos

Last Updated: Mar 29, 2026

Following the Dynamics of Structural Variants in Experimentally Evolved Populations
04:52

Following the Dynamics of Structural Variants in Experimentally Evolved Populations

Published on: February 3, 2023

1.4K
A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types
12:39

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types

Published on: December 10, 2012

11.8K

Area of Science:

  • Neuroscience
  • Computational Neuroscience
  • Statistical Modeling

Background:

  • Estimating conserved functional brain architectures across subjects is crucial for understanding neural mechanisms.
  • Integrating multi-subject electrophysiological data presents methodological challenges, particularly with nonlinear models.

Purpose of the Study:

  • To present a novel empirical Bayesian scheme for group or hierarchical models within dynamic causal modeling (DCM).
  • To address the methodological issue of integrating multi-subject measurements for inferring conserved functional brain architectures.

Main Methods:

  • Generalization of random effects analyses to Bayesian inference for nonlinear electrophysiological time-series data.
  • An empirical Bayesian scheme using iterative optimization of posterior densities with empirical priors from a second level.
  • Leveraging approximate Bayesian inference for hierarchical models to efficiently estimate group effects in DCM.

Main Results:

  • The proposed iterative scheme effectively addresses the local minima problem in nonlinear model inversion.
  • Empirical priors shrink first-level parameter estimates towards a global maximum, yielding more robust and efficient estimates.
  • The method enhances the estimation of both within- and between-subject effects.

Conclusions:

  • The developed empirical Bayesian approach provides a robust solution for estimating conserved functional brain architectures from multi-subject data.
  • This method improves the reliability and efficiency of dynamic causal modeling in group studies.
  • The technique offers a significant advancement for analyzing complex electrophysiological time-series data in neuroscience.